Câncer — Mama

termo de indexação original: Cancer - Breast

O acervo do Cannabis Indica reúne 118 estudos científicos que tocam a condição Câncer — Mama, publicados entre 1977 e 2024. Pela leitura automatizada, 103 (87%) foram classificados como favoráveis, 8 (7%) como inconclusivos e 7 (6%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é estudo laboratorial (55 estudos), seguido de metanálise (41). Os compostos mais presentes são Endocanabinoide (não especificado), Anandamida (AEA) e 2-Araquidonoilglicerol (2-AG). Aparece com frequência ao lado de Câncer, Câncer — Próstata e Câncer — Pulmão.

Estudos indexados: 118
Período coberto: 1977–2024
Favoráveis: 103 · 87%
Inconclusivos: 8 · 7%
Desfavoráveis: 7 · 6%
Termo original: Cancer - Breast

O acervo em números

Tipo de estudo

Estudo Laboratorial55

Metanálise41

Estudo em Animais16

Ensaio Clínico5

Metanálise Clínica1

Direção do resultado

Favorável103

Inconclusivo8

Desfavorável7

Por década

1970s1

1990s2

2000s12

2010s43

2020s60

Aparece junto com

Câncer115 Câncer — Próstata25 Câncer — Pulmão23 Dor21 Câncer — Cérebro20 Câncer — Cólon20 Câncer — Metastático20 Dor — Oncológica14

118 estudos

Filtrar e buscar no acervo →

2024
The Clinical Translation of α-humulene - A Scoping Review
FavorávelMetanáliseCâncer Inflamação Estresse Oxidativo Endocanabinoide (não especificado)+4
2023
Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy
FavorávelEstudo LaboratorialCâncer Inflamação Estresse Oxidativo THC Farmacêutico+12
2023
CBD-oil as a potential solution in case of severe tamoxifen-related side effects
FavorávelEnsaio ClínicoDor Câncer Insônia e Distúrbios do Sono+2
2023
Could cannabinoids provide a new hope for ovarian cancer patients?
FavorávelMetanáliseDor Câncer Inflamação Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+24
2022
A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment
FavorávelMetanáliseDor Câncer Ansiedade+5
2022
Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration
FavorávelEstudo LaboratorialCâncer Câncer — Metastático Osteoporose Anandamida (AEA)Endocanabinoide (não especificado)+2
2022
An In Silico Investigation to Explore Anti-Cancer Potential of Foeniculum vulgare Mill. Phytoconstituents for the Management of Human Breast Cancer
FavorávelEstudo LaboratorialCâncer
2022
Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer
FavorávelEstudo LaboratorialCâncer
2022
Anticancer activity of linalool: comparative investigation of ultrastructural changes and apoptosis in breast cancer cells
FavorávelEstudo LaboratorialCâncer Endocanabinoide (não especificado)
2022
Attitudes and Beliefs of Cancer Patients Demanding Medical Cannabis Use in the North of Thailand
FavorávelMetanáliseDor Câncer Ansiedade+5
2022
Biological effects of cannabidiol on human cancer cells: Systematic review of the literature
InconclusivoMetanáliseCâncer Inflamação Câncer — Cérebro Endocanabinoide (não especificado)Canabinol (CBN)+11
2022
Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1
FavorávelEstudo LaboratorialCâncer
2022
Cannabinoids as anticancer drugs: current status of preclinical research
FavorávelMetanáliseCâncer Câncer — Cérebro Câncer — Pulmão Anandamida (AEA)Endocanabinoide (não especificado)+24
2022
Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug
FavorávelMetanáliseDor Câncer Inflamação Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+18
2022
Cannabis with breast cancer treatment: propitious or pernicious?
DesfavorávelEstudo LaboratorialCâncer
2022
CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines
FavorávelEstudo LaboratorialCâncer Estresse Oxidativo Endocanabinoide (não especificado)
2022
Daily Consumption of Lemon and Ginger Herbal Infusion Caused Tumor Regression and Activation of the Immune System in a Mouse Model of Breast Cancer
FavorávelEstudo em AnimaisCâncer
2022
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist
FavorávelEstudo LaboratorialCâncer Câncer — Cérebro Câncer — Melanoma Endocanabinoide (não especificado)+1
2022
Different Cytotoxic Effects of Vetiver Oil on Three Types of Cancer Cells, Mainly Targeting CNR2 on TNBC
FavorávelEstudo LaboratorialCâncer
2022
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells
FavorávelEstudo LaboratorialCâncer Ácido Canabidiólico (CBD-a)
2022
Enhancing Cytotoxicity of Tamoxifen Using Geranium Oil
FavorávelEstudo LaboratorialCâncer
2022
Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study
DesfavorávelMetanáliseCâncer — Pulmão Câncer — Cólon Câncer — Próstata Delta-8-THC+16
2022
Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017
DesfavorávelMetanáliseCâncer Dependência — Álcool Canabigerol (CBG)
2022
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions
DesfavorávelMetanáliseCâncer Dependência — Nicotina Câncer — Cérebro Tetraidrocanabinol (THC)+16
2022
Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)
FavorávelEstudo LaboratorialDor Câncer Ansiedade+3
2022
In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center
FavorávelMetanáliseDor Câncer Ansiedade+14
2022
In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters
FavorávelEstudo LaboratorialCâncer Inflamação Depressão Canabicromeno (CBC)Ácido Canabicromênico (CBC-a)+1
2022
Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase
FavorávelEstudo LaboratorialCâncer Monoacilglicerol Lipase (MAGL)
2022
Investigation of the Effects of the Endogenous Cannabinoid Anandamide on Luminal A Breast Cancer Cell Line MCF-7
FavorávelEstudo LaboratorialCâncer Anandamida (AEA)Endocanabinoide (não especificado)
2022
Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
FavorávelMetanáliseDor Câncer Inflamação Tetraidrocanabinol (THC)Endocanabinoide (não especificado)+13
2022
Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
FavorávelEnsaio ClínicoDor Câncer Dor — Crônica Canabinol (CBN)Ácido Canabidiólico (CBD-a)+6
2022
Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer
FavorávelMetanáliseCâncer Câncer — Metastático
2022
Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells
FavorávelEstudo LaboratorialCâncer Canabicromeno (CBC)
2022
Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?
FavorávelMetanáliseDor Câncer Estresse Oxidativo Anandamida (AEA)Tetraidrocanabinol (THC)+14
2022
The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer
InconclusivoMetanáliseDor Câncer Obesidade Anandamida (AEA)Tetraidrocanabinol (THC)+17
2022
Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation
InconclusivoMetanáliseDor Câncer Estresse Oxidativo Anandamida (AEA)Endocanabinoide (não especificado)+15
2021
ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro
FavorávelEstudo LaboratorialCâncer — Pulmão Câncer — Cólon Câncer — Leucemia Endocanabinoide (não especificado)Canabinoides Sintéticos AM-x+1
2021
Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase
FavorávelMetanáliseCâncer Câncer — Cólon Câncer — Próstata Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
2021
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
FavorávelMetanáliseCâncer Câncer — Cérebro Câncer — Pulmão+1
2021
Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models
FavorávelEstudo LaboratorialCâncer Inflamação
2021
Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins
FavorávelEstudo LaboratorialCâncer Câncer — Cérebro Câncer — Metastático+2
2021
Cannabigerol and cannabichromene in Cannabis sativa L.
FavorávelMetanáliseCâncer Inflamação Ansiedade Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+12
2021
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
FavorávelEstudo LaboratorialCâncer Ácido Canabidiólico (CBD-a)
2021
Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis
FavorávelMetanálise ClínicaCâncer
2021
Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development
DesfavorávelMetanáliseCâncer Câncer — Leucemia Câncer — Fígado Canabigerol (CBG)Canabicromeno (CBC)+3
2021
Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer
FavorávelEstudo LaboratorialCâncer Canabitriol (CBT)
2021
N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol
FavorávelEstudo LaboratorialCâncer N-Araquidonoil Dopamina (NADA)
2021
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
FavorávelEstudo LaboratorialCâncer
2021
Tea tree oil extract causes mitochondrial superoxide production and apoptosis as an anticancer agent, promoting tumor infiltrating neutrophils cytotoxic for breast cancer to induce tumor regression
FavorávelEstudo LaboratorialCâncer Estresse Oxidativo Câncer — Cérebro Outros Compostos Relacionados+6
2021
Tetrahydrocannabinol and Its Major Metabolites are Not (or are poor) Substrates or Inhibitors of Human P-glycoprotein (P-gp/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2)
InconclusivoEstudo LaboratorialCâncer
2021
Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER + breast cancer cells: Impact on aromatase and steroid receptors
FavorávelEstudo LaboratorialCâncer Anandamida (AEA)Tetraidrocanabinol (THC)
2020
Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity
FavorávelEstudo LaboratorialCâncer Canabitriol (CBT)
2020
Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells
FavorávelEstudo LaboratorialCâncer Tetraidrocanabinol (THC)Canabigerol (CBG)+1
2020
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
FavorávelMetanáliseCâncer Anandamida (AEA)
2020
CBD Loaded Microparticles as a Potential Formulation to Improve Paclitaxel and Doxorubicin-Based Chemotherapy in Breast Cancer
FavorávelEstudo LaboratorialCâncer
2020
Insight of Druggable Cannabinoids Against Estrogen Receptor β in Breast Cancer
FavorávelEstudo LaboratorialCâncer
2020
JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice
InconclusivoEstudo em AnimaisCâncer Câncer — Próstata Osteoporose Monoacilglicerol Lipase (MAGL)+1
2020
n-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer
FavorávelMetanáliseCâncer
2020
Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction
DesfavorávelMetanáliseDor Câncer Dor — Oncológica
2020
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
FavorávelEstudo em AnimaisDor Câncer Dor — Oncológica 2-Araquidonoilglicerol (2-AG)Monoacilglicerol Lipase (MAGL)+1
2019
Anticancer Effects of n-3 EPA and DHA and Their Endocannabinoid Derivatives on Breast Cancer Cell Growth and Invasion
FavorávelEstudo LaboratorialCâncer Outros Compostos Relacionados
2019
Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
FavorávelEstudo em AnimaisCâncer Canabinoides Sintéticos O-x Canabidiol Anormal (Abn-CBD)
2019
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
FavorávelMetanáliseCâncer Endocanabinoide (não especificado)
2019
Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma
FavorávelEstudo em AnimaisDor Câncer Dor — Oncológica Canabinoides Sintéticos WIN-x+2
2019
Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy
FavorávelMetanáliseCâncer
2019
Future Aspects for Cannabinoids in Breast Cancer Therapy
FavorávelMetanáliseCâncer Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+12
2019
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers
InconclusivoMetanáliseCâncer Câncer — Cérebro Câncer — Próstata 2-Araquidonoilglicerol (2-AG)+3
2019
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
FavorávelEstudo LaboratorialCâncer Câncer — Cérebro
2019
The Endocannabinoid System of Animals
FavorávelMetanáliseDor Câncer Inflamação Anandamida (AEA)Endocanabinoide (não especificado)+21
2019
The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond
FavorávelMetanáliseCâncer Endocanabinoide (não especificado)Canabinoide Sintético (não especificado)+1
2019
Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer
FavorávelEstudo em AnimaisCâncer
2018
Anti-invasion Effects of Cannabinoids Agonist and Antagonist on Human Breast Cancer Stem Cells
FavorávelEstudo LaboratorialCâncer Canabinoides Sintéticos AM-x
2018
Appraising the "Entourage Effect": Antitumor Action of a Pure Cannabinoid Versus a Botanical Drug Preparation in Preclinical Models of Breast Cancer
FavorávelEstudo em AnimaisCâncer THC Farmacêutico
2018
C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells
FavorávelEstudo LaboratorialCâncer Ficocianina
2018
Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study
FavorávelEstudo LaboratorialCâncer Infecções Bacterianas Câncer — Cólon+2
2018
Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer
FavorávelEstudo LaboratorialCâncer
2018
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
FavorávelMetanáliseCâncer Esclerose Múltipla Câncer — Cérebro THC:CBD Farmacêutico CBD Farmacêutico+4
2018
The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling
DesfavorávelEstudo em AnimaisCâncer Lisofosfatidilinositol (LPI)
2017
Cannabidiolic Acid-mediated Selective Down-regulation Of C-fos In Highly Aggressive Breast Cancer MDA-MB-231 Cells: Possible Involvement Of Its Down-regulation In The Abrogation Of Aggressiveness
FavorávelEstudo LaboratorialCâncer Ácido Canabidiólico (CBD-a)
2017
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer Lines
FavorávelEstudo LaboratorialCâncer Câncer — Cérebro Ômega-3 Ômega-6
2016
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
FavorávelMetanáliseCâncer Câncer — Metastático Lisofosfatidilinositol (LPI)
2016
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
FavorávelMetanáliseNáusea e Vômito Náusea e Vômito por Quimioterapia Câncer — Pulmão THC Farmacêutico
2016
Integrating cannabis into clinical cancer care
FavorávelMetanáliseDor Câncer Náusea e Vômito THC:CBD Farmacêutico+10
2016
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
FavorávelMetanáliseCâncer Câncer — Próstata Endocanabinoide (não especificado)Canabinoide Sintético (não especificado)
2016
Simultaneous Activation Of Induced Heterodimerization Between CXCR4 Chemokine Receptor And Cannabinoid Receptor 2 (CB2) Reveal A Mechanism For Regulation Of Tumor Progression
FavorávelEstudo LaboratorialDor Câncer HIV/AIDS Canabinoides Sintéticos AM-x Canabinoides Sintéticos JWH-x+3
2016
The antitumor effects of geraniol: Modulation of cancer hallmark pathways
FavorávelMetanáliseCâncer Câncer — Pulmão Câncer — Cólon+3
2016
β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties.
FavorávelMetanáliseDor Câncer Inflamação+16
2015
Anti-invasive effect of β-myrcene, a component of the essential oil from Pinus koraiensis cones, in metastatic MDA-MB-231 human breast cancer cells
FavorávelEstudo LaboratorialCâncer
2015
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway; novel anti-tumor mechanisms of Cannabidiol in breast cancer
FavorávelEstudo em AnimaisCâncer
2015
Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
FavorávelEstudo LaboratorialCâncer Ficocianina
2015
Phytol Induces Apoptosis and ROS-Mediated Protective Autophagy in Human Gastric Adenocarcinoma AGS Cells
FavorávelEstudo LaboratorialCâncer Câncer — Pulmão Câncer — Cólon+1
2015
Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.
FavorávelEstudo em AnimaisCâncer
2014
Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.
FavorávelEstudo LaboratorialCâncer
2014
Targeting Multiple Cannabinoid Anti-tumour Pathways With A Resorcinol Derivative Leads To Inhibition Of Advanced Stages Of Breast Cancer
FavorávelEstudo em AnimaisCâncer Câncer — Metastático Canabinoides Sintéticos O-x
2013
Critical Appraisal Of The Potential Use Of Cannabinoids In Cancer Management
FavorávelMetanáliseCâncer Câncer — Cérebro Câncer — Pulmão Endocanabinoide (não especificado)Canabinoide Sintético (não especificado)+2
2013
Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer.
FavorávelEnsaio ClínicoCâncer
2012
Cannabidiol As Potential Anticancer Drug
FavorávelMetanáliseCâncer Câncer — Cérebro Câncer — Pulmão Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
2012
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.
FavorávelEstudo LaboratorialCâncer Ácido Canabidiólico (CBD-a)
2011
b-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation.
FavorávelEstudo LaboratorialCâncer Câncer — Próstata
2011
Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
FavorávelMetanáliseDor Câncer Inflamação Anandamida (AEA)Endocanabinoide (não especificado)+23
2011
Pathways Mediating The Effects Of Cannabidiol On The Reduction Of Breast Cancer Cell Proliferation, Invasion, And Metastasis
FavorávelEstudo em AnimaisCâncer Câncer — Pulmão
2011
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
FavorávelMetanáliseCâncer Ansiedade Depressão+1
2010
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
FavorávelEstudo em AnimaisCâncer Tetraidrocanabinol (THC)Canabinoides Sintéticos JWH-x
2009
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
FavorávelEstudo em AnimaisCâncer Câncer — Metastático Canabinoides Sintéticos AM-x Canabinoides Sintéticos WIN-x+2
2008
JunD Is Involved In The Antiproliferative Effect Of Δ9-tetrahydrocannabinol On Human Breast Cancer Cells
FavorávelEstudo LaboratorialCâncer
2008
Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
FavorávelEstudo LaboratorialCâncer
2008
Management of bone metastases
FavorávelMetanáliseDor Câncer Dor — Oncológica THC:CBD Farmacêutico+8
2007
Cannabidiol As A Novel Inhibitor Of Id-1 Gene Expression In Aggressive Breast Cancer Cells
FavorávelEstudo LaboratorialCâncer
2007
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
FavorávelEstudo em AnimaisCâncer Estresse Oxidativo Câncer — Cérebro Canabinoides Sintéticos SR-x Canabinoides Sintéticos HU-x+1
2007
Potentiating Effect Of Beta-caryophyllene On Anticancer Activity Of Alpha-humulene, Isocaryophyllene And Paclitaxel
FavorávelEstudo LaboratorialCâncer
2006
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
FavorávelEstudo em AnimaisCâncer Câncer — Pulmão Câncer — Tireoide Tetraidrocanabinol (THC)Canabigerol (CBG)+2
2006
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism
FavorávelEstudo LaboratorialCâncer Canabinoides Sintéticos SR-x
2006
Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression In Human Breast Cancer Cells Through Cdc2 Regulation
FavorávelEstudo LaboratorialCâncer Tetraidrocanabinol (THC)
2000
Phase I pharmacokinetic trial of perillyl alcohol in patients with refractory solid malignancies
InconclusivoEnsaio ClínicoCâncer Câncer — Próstata
2000
Suppression Of Nerve Growth Factor Trk Receptors And Prolactin Receptors By Endocannabinoids Leads To Inhibition Of Human Breast And Prostate Cancer Cell Proliferation
FavorávelEstudo LaboratorialCâncer Câncer — Próstata Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
1998
Phase I and Pharmacokinetic Study of D-limonene in Patients With Advanced Cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee
FavorávelEnsaio ClínicoCâncer
1998
The Endogenous Cannabinoid Anandamide Inhibits Human Breast Cancer Cell Proliferation
FavorávelEstudo LaboratorialCâncer Anandamida (AEA)Canabinoides Sintéticos HU-x
1977
Isolation and characterization of (+)-cannabitriol and (-)-10-ethoxy-9-hydroxy-delta 6a[10a]-tetrahydrocannabinol: two new cannabinoids from Cannabis sativa L. extract
InconclusivoEstudo LaboratorialCâncer Canabitriol (CBT)

Continue por aqui

Canabinoides e compostos

Endocanabinoide (não especificado) 19 Anandamida (AEA) 18 2-Araquidonoilglicerol (2-AG) 15 Canabigerol (CBG) 10 Tetraidrocanabinol (THC) 9 Canabicromeno (CBC) 9 Canabinoides Sintéticos AM-x 8 Canabinoides Sintéticos WIN-x 8

Sistemas do corpo

Sistema Reprodutor 73 Sistema Nervoso 70 Sistema Digestório 2 Sistema Endócrino 2 Sistema Esquelético 2 Sistema Cardiovascular 1

Perguntas frequentes

Quantos estudos sobre câncer — mama estão indexados no acervo?

São 118 estudos, publicados entre 1977 e 2024. O acervo inteiro tem 7.640 registros.

Que tipos de estudo predominam?

Estudo Laboratorial: 55 · Metanálise: 41 · Estudo em Animais: 16 · Ensaio Clínico: 5 · Metanálise Clínica: 1. A classificação segue o desenho declarado na fonte.

O que significa a classificação de resultado?

É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 103 favoráveis, 8 inconclusivos e 7 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Câncer — Mama — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/cancer-mama/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Câncer — Mama — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/cancer-mama/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.